RACHEL SCHOLLAERT-CULWELL: Open Payments
NPI 1376149856 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 23 payments from 13 companies in 2025. Trend: 2023 $13 · 2024 $42 · 2025 $469
Food & beverage: $469
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 4 | $91 |
| SpringWorks Therapeutics, Inc. | 3 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $67 |
| Neurelis, Inc. | 2 | $43 |
| Alexion Pharmaceuticals, Inc. | 2 | $38 |
| ARGENX US, INC. | 2 | $35 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| CATALYST PHARMACEUTICALS, INC. | 1 | $22 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $22 |
| EMD Serono, Inc. | 1 | $22 |
Products named: GOMEKLI, HYQVIA, Rystiggo, VALTOCO, ULTOMIRIS, VYVGART HYTRULO, Nayzilam, ONPATTRO.
Industry payments across KY — which companies pay providers there.
